• About Us
  • Copyright Policy
  • Disclaimer
  • Authors
  • Career
  • Contact Us
Assamese |   Bengali |  
Thursday, January 28, 2021
NORTHEAST NOW
  • HOME
  • NORTH EAST
    • Assam
    • Meghalaya
    • Tripura
    • Mizoram
    • Manipur
    • Nagaland
    • Arunachal
    • Sikkim
  • Neighbours
    • Nepal
    • Bhutan
    • China
    • Myanmar
    • Bangladesh
  • Business
  • Entertainment
  • Sports
  • Environment
  • Citizen Journalists
  • Opinion
No Result
View All Result
  • HOME
  • NORTH EAST
    • Assam
    • Meghalaya
    • Tripura
    • Mizoram
    • Manipur
    • Nagaland
    • Arunachal
    • Sikkim
  • Neighbours
    • Nepal
    • Bhutan
    • China
    • Myanmar
    • Bangladesh
  • Business
  • Entertainment
  • Sports
  • Environment
  • Citizen Journalists
  • Opinion
No Result
View All Result
NORTHEAST NOW
Assamese
Home Health

COVID-19: India bans HCQ export; Trump asks Modi for urgent supply

NE NOW NEWS by NE NOW NEWS
GUWAHATI , April 6, 2020 8:10 am
COVID-19: India bans HCQ export; Trump asks Modi for urgent supply

File image of the US President Donald Trump with Prime Minister Narendra Modi

Share on FacebookShare on Twitter

India has imposed a blanket ban on the export of the anti-malaria drug hydroxychloroquine (HCQ).

Notably, almost all the countries bogged down by the COVID-19 pandemic are looking up to the anti-malarial drug as a possible cure of novel coronavirus.

According to The Print, even the US President Donald Trump has requested Prime Minister Narendra Modi for an urgent supply of the drug.

The drug has been touted as a ‘game-changer’ in the fight against the disease that has infected more than 1.2 million people worldwide and induced a global recession in just a few months.

In India, the number of cases jumped to over 3,000 in 10 days.

Trade regulator Directorate General of Foreign Trade (DGT) Saturday issued the ban on the drug and its formulations, modifying a March 25 order that allowed trade with ‘limited exceptions’, such as on humanitarian grounds and for meeting prior commitments.

It had also allowed exports from special economic zones (SEZs) or from Export Oriented Units (EOUs).

Incidentally, the move came when Trump said he requested Prime Minister Narendra Modi to ensure India supplies the drug.

It, however, remains unclear whether the order was issued before or after Trump’s call.

India is a leading global player in the manufacturing of HCQ with Ipca laboratories, Zydus Cadila, Wallace Pharmaceuticals and Cipla as top pharma companies.

A derivative of chloroquine, HCQ has lesser side-effects.

India’s move to ban the export of HCQ will ensure sufficient domestic supply as the country braces for a more dire situation.

Tags: COVID19
TikTok

Ban impact: TikTok scales down India operation

flood

Only adaptive capacity can reduce flood miseries in Assam: NGO

Goalpara DC

Assam: Goalpara DC launches Jal Shakti ministry programme ‘Catch the Rain’

3 ULFA(I) cadres

Assam Rifles personnel nab 3 ULFA(I) cadres in Arunachal Pradesh’s Tirap district   

NORTHEAST NOW

Northeast Now is a multi-app based hyper-regional bilingual news portal. Led by a group of professionals, the digital news platform covers every inch of the eight states of northeast India and the five neighbouring countries. It is the first of its kind new media initiative in the northeast, and is based in Guwahati. As the political dynamics in the northeast is intricate and fluid, Northeast Now is always politically neutral.

 
Our Properties
 
  • NORTHEAST NOW ASSAMESE
  • NORTHEAST JOBS
  • NORTHEAST TENDERS
  • INNFINITY
  • About Us
  • Copyright Policy
  • Disclaimer
  • Authors
  • Career
  • Contact Us

© 2019 - Maintained by EZEN Software & Technology Pvt. Ltd

No Result
View All Result
  • HOME
  • NORTH EAST
    • Assam
    • Meghalaya
    • Tripura
    • Mizoram
    • Manipur
    • Nagaland
    • Arunachal
    • Sikkim
  • Neighbours
    • Nepal
    • Bhutan
    • China
    • Myanmar
    • Bangladesh
  • Business
  • Entertainment
  • Sports
  • Environment
  • Citizen Journalists
  • Opinion

© 2019 - Maintained by EZEN Software & Technology Pvt. Ltd